We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Next-Generation Hematology Analyzer Introduced

By LabMedica International staff writers
Posted on 04 Jul 2017
Hematology is a medical specialty dedicated to studying the physiology of blood, and the cause, diagnosis, treatment, and prevention of diseases related to blood. More...
In diagnostics testing, hematology tests look at blood composition, which includes the identification and quantification of different types of blood cells.

The Alinity hq analyzer (Abbott, Abbott Park, IL, USA) for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark. The analyzer is the first in the Alinity hematology series of instruments to be commercially released, and is part of the planned integrated hematology system designed to address the productivity needs of the high-volume laboratory. The Alinity hq was built from the ground up to help solve every day operational challenges and anticipated future needs for high-volume laboratories.

Some unique capabilities of the Alinity hq system include: Innovative, advanced optical technology combined with robust algorithms to handle normal and pathological samples. Design features that are intended to reduce manual steps and minimize errors, improve confidence in data and allow for uninterrupted operation and scalable, modular design to customize configurations to better serve a broad spectrum of laboratories.

As part of the Alinity family of harmonized systems, the Alinity hq analyzer has an intuitive user interface with iconography, color coding and reporting features shared by all Alinity instruments. The Alinity family also uses a common method for sample loading and reagent management, which helps laboratories simplify technician training. The Alinity portfolio includes clinical chemistry, immunoassay, blood and plasma screening, point of care, hematology and molecular diagnostics.

Luis de Luzuriaga, divisional vice president and general manager for Abbott’s hematology business, said, “The Alinity hq launch is a key milestone for Abbott’s hematology business unit. Abbott is leading the way to providing a more efficient, complete laboratory solution that no competitor in the industry can match. With the Alinity family of harmonized systems, Abbott aims to simplify diagnostics testing across laboratory disciplines and help our customers improve patient outcomes.”


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.